# A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)

> **NCT00891202** · PHASE3 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 40 (actual)

## Conditions studied

- Gaucher Disease, Type 1

## Interventions

- **DRUG:** Eliglustat tartrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00891202
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2012-07
- **Final completion:** 2016-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00891202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00891202, "A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00891202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*